早期的经验是用KONAR-MF多功能封闭器关闭过导管心室隔膜缺陷
Abdelrahman Elafifi1, Susy Kotit1, Mahmoud Shehata1
1Pediatric Cardiology, Aswan Heart Centre, Aswan, Egypt.
Frontiers in pediatrics
|April 22, 2025
概括
使用LifetechTM Konar多功能封闭器 (MFO) 装置,通过导管关闭心室隔膜缺陷 (VSD) 是安全有效的. 这项研究显示,VSD关闭的成功率高,并发症可控.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 儿童心脏病学 儿童心脏病学
背景情况:
- 过导管装置的关闭是一种对心室隔膜缺陷 (VSD) 的手术修复的微创替代方案.
- 由于其多功能性,LifetechTM Konar多功能封闭器 (MFO) 越来越多地用于VSD封闭.
研究的目的:
- 评估MFO设备的安全性和有效性,用于穿皮VSD关闭.
- 评估与MFO设备植入相关的程序结果和并发症.
主要方法:
- 用MFO设备进行静脉关闭的151名患者的前性分析 (2018年11月 - 2023年9月).
- 包括肌肉和周膜性VSD.
- 评估手术成功,手术时间,光镜时间和后续数据.
主要成果:
- 在98.7%的患者中成功植入设备.
- 平均手术时间:44分钟;平均光镜时间:12.8分钟.
- 并发症包括不显著的残留位 (21.2%),新获得的膜吐 (10.6%),以及血管并发症 (8.6%).
结论:
- 使用MFO装置进行皮肤穿透式VSD关闭是一种安全,有效和可行的选择.
- 在VSD关闭中,MFO设备在前级和后级两种方法中都显示出有希望的结果.
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


